The trading update looks good too!
By way of a trading update prior to commencing the buyback, the Company has made a positive start to the year, with 1Q23 sales expected to be marginally ahead of plan primarily reflecting the benefit of favourable foreign exchange driven by depreciation of the New Zealand Dollar (NZD). Due to the currency impact on cost of sales and cost of doing business, notwithstanding the benefit to sales, 1Q23 EBITDA is expected to be in line with plan.Consistent with the Company’s outlook statement on 29 August 2022, in addition to trading upside and downside, other business and industry risks include, but are not limited to, COVID-19 impacts on supply chain, SAMR registration process timing, volume impact of price increases, foreign exchange movements, cross border trade, changes in the regulatory environment, and commodity prices. These risks could materially impact expected revenue and earnings outcomes.
- Forums
- ASX - By Stock
- Ann: Share buyback to commence 5 October - 1Q23 Trading update
The trading update looks good too!By way of a trading update...
-
- There are more pages in this discussion • 10 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add A2M (ASX) to my watchlist
(20min delay)
|
|||||
Last
$5.28 |
Change
0.090(1.73%) |
Mkt cap ! $3.822B |
Open | High | Low | Value | Volume |
$5.23 | $5.29 | $5.14 | $18.87M | 3.614M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 12652 | $5.27 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$5.29 | 3513 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 10000 | 5.270 |
1 | 5 | 5.230 |
1 | 133 | 5.220 |
7 | 3303 | 5.200 |
2 | 100000 | 5.180 |
Price($) | Vol. | No. |
---|---|---|
5.300 | 648 | 2 |
5.310 | 1291 | 3 |
5.320 | 100 | 1 |
5.330 | 2000 | 1 |
5.350 | 379 | 1 |
Last trade - 16.10pm 08/11/2024 (20 minute delay) ? |
Featured News
A2M (ASX) Chart |
The Watchlist
EQN
EQUINOX RESOURCES LIMITED.
Zac Komur, MD & CEO
Zac Komur
MD & CEO
SPONSORED BY The Market Online